Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Okada, H.
Right arrow Articles by Kanzaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okada, H.
Right arrow Articles by Kanzaki, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 7, No. 4, 341-347, April 2001
© 2001 European Society of Human Reproduction and Embryology

The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro

Hidetaka Okada1,, Tatsuya Nakajima, Tomoo Yoshimura, Katsuhiko Yasuda and Hideharu Kanzaki

Department of Obstetrics and Gynecology, Kansai Medical University, Moriguchi 570-8507, Japan

Dienogest is a synthetic steroid that has been used as a progestogen in contraceptive pills and is currently being studied for its possible clinical use in the treatment of endometriosis. In this study, we investigated the direct effects of dienogest in differentiation and proliferation of human endometrial stromal cells (ESC) in vitro. After 12 days in the presence of oestradiol (10–8 mol/l) plus dienogest (10–6 mol/l), cultured ESC underwent morphological differentiation and produced prolactin, a typical marker for decidualization. By using Northern blot analysis and radioimmunoassay, it was shown that treatment of ESC with oestradiol (10–8 mol/l) plus dienogest (10–9 to10–6 mol/l) led to an increase in the levels of prolactin mRNA and prolactin production in a dose-dependent manner. Additionally, RU-486, a progesterone receptor antagonist, almost completely inhibited dienogest-induced prolactin production. As shown by the thymidine uptake method, there was a dose-dependent inhibition of ESC proliferation with dienogest (P < 0.01, control versus concentrations >10–7 mol/l). The significant inhibition of ESC proliferation by dienogest (10–7 mol/l) was partially reversed by RU-486 (10–6 mol/l). In summary, dienogest directly acts on endometrial tissue in progestogenic response, such as decidualization, increased prolactin production and growth retardation. These data imply that dienogest exerts direct effect in suppressing growth of endometriotic implants.

decidualization/dienogest/endometrial stromal cells/endometrium/proliferation

1 To whom correspondence should be addressed. E-mail: hokada{at}takii.kmu.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
Y. Shimizu, T. Takeuchi, S. Mita, K. Mizuguchi, T. Kiyono, M. Inoue, and S. Kyo
Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression
Mol. Hum. Reprod., October 1, 2009; 15(10): 693 - 701.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. Wieser, J. Yu, J. Park, A. Gaeddert, M. Cohen, J.-L. Vigne, and R. N. Taylor
A Botanical Extract from Channel Flow Inhibits Cell Proliferation, Induces Apoptosis, and Suppresses CCL5 in Human Endometriotic Stromal Cells
Biol Reprod, August 1, 2009; 81(2): 371 - 377.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.